Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein , Helen M. Colhoun , Gilles R. Dagenais +97 more 2019 The Lancet 2683 citations
Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status Gee‐Chen Chang , Kun‐Chieh Chen , Tsung‐Ying Yang +4 more 2004 Investigational New Drugs 41 citations